Return to homepagePandemic Pact

Safety of hydroxychloroquine and azithromycin treatment in COVID-19 patients - a probe-COVID-trial substudy, Hvidovre Hospital

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Known Financial Commitments (USD)

    $68,800

  • Funder

    Novo Nordisk Foundation

  • Principal Investigator

    N/A

  • Research Location

    Denmark

  • Lead Research Institution

    Hvidovre Hospital:

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Prophylactic use of treatments

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Unspecified

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

The project is a supplementary project to the research project "Proactive protection of inpatients with COVID-19 lung disease - Pro-Lung-COVID trial", for which the University of Copenhagen and Capital Region of Denmark received a grant from the Novo Nordisk Foundation last month. This project will focus on examining the safety of a combined treatment using the medications hydroxychloroquine and azithromycin. The purpose of this project is to safeguard the clinical applicability of this combined treatment.